Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,284 across all filing types
Latest filing 2024-06-11 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
关于控股股东部分股份解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding the release of pledged shares by a controlling shareholder. It details the number of shares released from pledge, cumulative pledge status, and reassures no change in control or operational impact. The document is short (1390 characters) and focuses on share pledge status, not financial results or management changes. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership or share pledge status by major shareholders.
2024-06-11 Chinese
第五届监事会第十二次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Tianjin Ruipu Biotechnology Co., Ltd. It details the meeting held on June 11, 2024, including the approval of several proposals related to the 2022 restricted stock incentive plan, such as lifting restrictions on shares, repurchase and cancellation of shares, and adjustment of repurchase price. The document includes voting results and references to other announcements published on the Shenzhen Stock Exchange and CNINFO websites. The content is about board-level decisions and approvals rather than a full financial report or earnings release. It is not a full annual or interim report, nor a call transcript or capital update. It is a formal announcement of board resolutions, which fits best under Board/Management Information (MANG). The document length is short (1561 characters), and it contains substantive content about board decisions, not just a report publication announcement or certification. Therefore, the classification is MANG with high confidence.
2024-06-11 Chinese
关于2022年限制性股票激励计划第二个解除限售期解除限售条件成就的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the achievement of conditions for the second release period of a 2022 restricted stock incentive plan by Tianjin Ruipu Biotechnology Co., Ltd. It includes specifics about the number of shares released, the number of participants, approval procedures, legal and financial advisor opinions, and board and supervisory committee resolutions. The content focuses on stock incentive plan details, share release conditions, and related corporate governance matters. It is not a financial report, earnings release, or regulatory filing in the usual sense, but rather an official announcement about share-based compensation and stock unlocking. This fits best under the category of Regulatory Filings (RNS) as it is a regulatory announcement about share incentive plan progress and share release, not a full report or financial statement.
2024-06-11 Chinese
关于召开2024年第一次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about convening the 2024 first extraordinary general meeting (临时股东大会) of Tianjin Ringpu Biotechnology Co., Ltd. It includes information about the meeting date, voting procedures (both onsite and online), agenda items including proposals for stock repurchase and amendment of company articles, registration details, and proxy voting instructions. The document does not contain financial statements or results but is a formal announcement to shareholders about the meeting and voting process. It is not a report of the meeting results or a financial report. Given the content and length (4339 characters), it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2024-06-11 Chinese
关于回购注销2022年限制性股票激励计划部分限制性股票的公告
Transaction in Own Shares Classification · 95% confidence The document is an official announcement from Tianjin Ruipu Biotechnology Co., Ltd. regarding the repurchase and cancellation of restricted stock under the 2022 restricted stock incentive plan. It details the approval procedures, reasons for repurchase and cancellation, pricing adjustments, impact on share capital structure, and legal opinions. The content focuses on corporate actions related to stock repurchase and cancellation of shares under an incentive plan, including board and shareholder approvals. It does not contain financial statements or quarterly/yearly financial results, nor is it a transcript, presentation, or legal proceeding update. The document is a formal announcement of a share repurchase and cancellation event, which fits the category of Transaction in Own Shares (POS). The document length is over 5,000 characters and contains detailed information about the transaction, not just a brief notice or report publication announcement.
2024-06-11 Chinese
第五届董事会第十五次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board of directors meeting of Tianjin Ruipu Biotechnology Co., Ltd. It details the meeting date, attendance, and specific agenda items such as approval of stock incentive plans, stock repurchase and cancellation, amendments to the company charter, and the scheduling of a shareholders meeting. The document does not contain financial statements or detailed financial analysis but rather reports on board decisions and corporate governance matters. It is not an annual or interim report, earnings release, or audit report. It is not a proxy solicitation or voting results announcement. The content fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management.
2024-06-11 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.